“Our team has a proven record developing and commercializing therapies that improve patient care and outcomes”.
[image placeholder – do not delete]
The foremost purpose of each of our leadership teams is to provide support, guidance and expertise to ensure the success of each development program within our portfolio of companies. Cognizant of our role as a critical growth engine for Sumitomo Pharma, we continually seek new assets to enhance our robust and diverse pipeline and are transforming the drug development process to deliver new medicines to market faster.
We bring new medicines to patients more rapidly.Dan Rothman, Chief Information Officer
Q&A with Dan Rothman, Chief Information Officer at Sumitovant
Sumitovant’s Chief Information Officer, Dan Rothman, elaborates on our key technology platforms and how they may potentially help us bring new medicines more quickly to those who need them most.